Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through ...
A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory ...
Abstract: During operation, wind turbine systems are affected by external wind speed disturbances and the dynamic coupling of the system, which can lead to significant resonance phenomena within ...
Ms. Jinhua Zhang, Founder, Chairwoman, and CEO of IASO Bio, stated: "We are delighted that the New Drug Application for Equecabtagene Autoleucel has been officially accepted by the Hong Kong ...
The new drug combination reduced the risk of disease progression or death by 27%, with patients on the Calquence combination living an average of 66.4 months without their cancer getting worse ...
The FDA requested new and updated information and clarifications related to drug substance, drug product, manufacturing, and microbiology. The FDA did not express concern about the stability of the ...
Eton Pharmaceuticals, Inc. announced that the FDA has extended the PDUFA goal date for its New Drug Application (NDA ... and accomplish certain goals and objectives. These statements include ...
Add articles to your saved list and come back to them any time. Hundreds of thousands of doses of a new drug to treat a major disease are being handed out to patients this week after a small ...
According to Lambert, the wound dressings are on track for regulatory submission as medical devices, which, if approved, offers a faster pathway to market compared to new drug applications.
The new treatment targets inflammation directly within the joints so that therapeutic agents are released only when needed. The approach is different from traditional treatments that often rely on ...